Itranols

Itraconazole, the active ingredient in Itranols, is a triazole antifungal presented as an oral formulation for oral use. It is prescribed to treat a variety of systemic and superficial fungal infections in both adult and pediatric patients when indicated by a healthcare professional.

GNH USA supplies Itranols as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, transplant centres, oncology centres, pharmacies and clinics worldwide.

Itraconazole is an azole antifungal used to manage systemic and localized fungal diseases.

- Blastomycosis: eradicates the infection and reduces risk of relapse. - Histoplasmosis: clears the organism from affected tissues and prevents dissemination. - Aspergillosis: controls invasive disease and improves survival in at‑risk patients. - Candidiasis (oropharyngeal and esophageal): relieves symptoms and eliminates Candida overgrowth. - Dermatophytosis: treats skin and nail infections caused by dermatophytes. - Sporotrichosis: resolves cutaneous and lymphocutaneous disease.

Itraconazole may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Nausea: mild stomach upset occurring early in therapy. - Headache: transient headache reported by some patients. - Abdominal pain: discomfort or cramping in the gastrointestinal tract. - Rash: mild skin erythema or itching.

Serious or Rare Side Effects: - Hepatotoxicity: elevated liver enzymes or hepatitis requiring monitoring. - Cardiac failure: rare cases of congestive heart failure, especially in patients with pre‑existing heart disease. - Severe hypersensitivity: anaphylactic reactions or Stevens‑Johnson syndrome.

When prescribing itraconazole, clinicians should consider several safety measures to minimize risk.

- Liver function monitoring: assess baseline enzymes and repeat during therapy. - Drug‑interaction review: avoid concomitant use with strong CYP3A4 inhibitors or inducers. - Cardiac assessment: evaluate for existing heart failure before initiating treatment. - Pregnancy and lactation: use only if potential benefit outweighs risk, as safety data are limited. - Patient counseling: advise on adherence, possible side effects, and need for regular follow‑up. - Store at ambient temperature: keep below 25 °C in the original container, protect from moisture and light.

Itraconazole interacts with several medicines through CYP3A4 modulation and other pathways.

Major Interactions (Avoid): - Ketoconazole: combined use may cause severe hepatotoxicity. - Rifampicin: potent inducer reduces itraconazole exposure, compromising efficacy. - Certain statins (e.g., simvastatin): increased risk of myopathy and rhabdomyolysis. - HIV protease inhibitors (e.g., ritonavir): can lead to toxic itraconazole levels. - Ergot derivatives: heightened risk of ergotism due to elevated plasma concentrations.

Moderate Interactions (Monitor Closely): - Calcium channel blockers (e.g., amlodipine): may require dose adjustment. - Benzodiazepines (e.g., midazolam): increased sedation, monitor effect. - Anticoagulants (e.g., warfarin): possible alteration of INR, monitor coagulation. - Oral contraceptives: reduced efficacy, advise backup contraception. - Antacids containing aluminum or magnesium: may decrease absorption, separate dosing by at least 2 hours.